ASST Strive, Inc. (NASDAQ) 03 Feb 2026 down 5.68%: earnings Feb 9 may reset valuation

ASST stock fell 5.68% to $0.68 at market close on 03 Feb 2026 as traders priced in the company’s Feb 9 earnings report. Volume was heavy at 185,670,742 shares, almost double the 50-day average. This move follows recent volatility and a low 50-day average of $0.93, making the upcoming report a potential catalyst for a sharp re-rating.

Today’s price action and what moved the market

Strive, Inc. (ASST) closed at $0.68 on NASDAQ in the United States after opening at $0.73. The one-day decline of 5.68% came with a relVolume of 1.83, signaling outsized selling. Traders cited macro pressure on crypto-linked funds and follow-on offering chatter as drivers. Recent company news and coverage from MarketBeat and Seeking Alpha increased headline risk for short-term holders MarketBeat Seeking Alpha.

Earnings spotlight: Feb 9 report and key metrics to watch

ASST earnings are scheduled for 09 Feb 2026. Investors should watch Bitcoin per share disclosures and net management fees. Latest TTM metrics show EPS -0.04 and a negative PE. The company uses Bitcoin holdings as a treasury strategy, so crypto price moves and custody metrics will matter. Guidance or a change in treasury policy will likely move ASST stock sharply around the release.

Financial snapshot and valuation context

Strive, Inc. reports a market cap of $851,001,572 and shares outstanding of 1,050,000,000. Key ratios include PB 0.00 and priceAvg200 $3.23, highlighting long-term decline from a year high $13.42 to a year low $0.39. Cash per share is strong at $49.00, while operating cash flow per share is negative $15.10. These mixed metrics explain the low trading price and elevated volatility in ASST stock.

Technical view and Meyka AI grade

Technicals show RSI 56.01 and ADX 25.92, suggesting a trending market with moderate momentum. Bollinger mid is $0.88 and day range was $0.62–$0.73. Meyka AI rates ASST with a score out of 100: 58.40 (Grade C+, Suggestion: HOLD). This grade factors S&P 500 comparison, sector trends, financial growth, key metrics, and analyst sentiment.

Price targets, forecasts and scenario planning

Meyka AI’s forecast model projects a yearly price of $3.12 and a monthly price of $0.96. Using the current price of USD 0.6821, the 12-month forecast implies +357.24% upside, while the monthly forecast implies +40.74%. Short-term targets: conservative $0.95, base $3.00, and bull $5.50. These targets assume stable Bitcoin holdings and no dilutive capital raises.

Risks, catalysts and suggested investor approaches

Primary risks include Bitcoin price swings, dilution from follow-on offerings, and negative operating cash flows. Catalysts are the Feb 9 earnings report, any change in treasury policy, and regulatory news on crypto funds. For traders, earnings week suggests tight risk controls and stop levels. For longer-term investors, monitor cash per share and treasury performance before adding ASST stock to a portfolio.

Final Thoughts

Key takeaways for ASST stock: the shares dropped 5.68% on 03 Feb 2026 ahead of the Feb 9 earnings report. Strive, Inc. shows strong cash per share ($49.00) but negative operating cash flow per share (-$15.10) and a volatile trading history. Meyka AI’s forecast model projects a yearly price of $3.12, implying +357.24% from the current USD 0.6821. Our view is cautious: the C+ grade and HOLD suggestion reflect mixed fundamentals and sector sensitivity to Bitcoin. Traders should treat the Feb 9 report as a binary event and set clear risk limits. Long-term investors should wait for sustained cash-flow improvement or clearer treasury gains before increasing exposure. Meyka AI provides this analysis as an AI-powered market analysis platform. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.